再生障碍性贫血的免疫抑制治疗：我们是否已达到极限？
Immunosuppressive treatment for aplastic anemia: are we hitting the ceiling?
作者信息
Passweg Jakob R, Tichelli André
出版信息
Haematologica. 2009 Mar;94(3):310-2. doi: 10.3324/haematol.2008.002329.
Abstract
The combination of antithymocyte globulin of horse origin and cyclosporine A is the standard treatment for aplastic anemia in patients not eligible for bone marrow transplantation. In this perspective article, Drs. Passweg and Tichelli discuss the current immunosuppressive therapy of aplastic anemia. See related article on page 348.
摘要
马源性抗胸腺细胞球蛋白与环孢素A联合使用是不适于进行骨髓移植的再生障碍性贫血患者的标准治疗方法。在这篇观点文章中，帕斯韦格博士和蒂凯利博士讨论了再生障碍性贫血目前的免疫抑制疗法。见第348页的相关文章。
相似文献
1
Immunosuppressive treatment for aplastic anemia: are we hitting the ceiling?
Haematologica. 2009 Mar;94(3):310-2. doi: 10.3324/haematol.2008.002329.
2
Relapse of aplastic anemia responsive to sirolimus combined with cyclosporine.
Pediatr Blood Cancer. 2011 Jul 1;56(7):1133-5. doi: 10.1002/pbc.22865. Epub 2011 Feb 11.
3
Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study.
Haematologica. 2009 Mar;94(3):348-54. doi: 10.3324/haematol.13829. Epub 2009 Jan 30.
4
Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine.
Semin Hematol. 2000 Jan;37(1):56-68. doi: 10.1016/s0037-1963(00)90030-1.
5
Antithymocyte globulin and cyclosporin in children with acquired aplastic anemia.
Indian J Pediatr. 2009 Sep;76(9):970-1; author reply 971-2. doi: 10.1007/s12098-009-0104-3.
6
Severe aplastic anaemia--complete response to antilymphocyte globulin and cyclosporin.
West Indian Med J. 1999 Dec;48(4):238-9.
7
Immunosuppression with ALG and CsA is first line treatment in children with SAA lacking an HLA identical sibling.
Pediatr Blood Cancer. 2005 Sep;45(3):359-60; author reply 361-2. doi: 10.1002/pbc.20418.
8
[Immunosuppressive therapy for aplastic anemia--review].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Apr;13(2):348-52.
9
Merkel cell carcinoma developing after antithymocyte globulin and cyclosporine therapy for aplastic anemia.
Anticancer Drugs. 2003 Mar;14(3):251-3. doi: 10.1097/00001813-200303000-00010.
10
Immune suppression for childhood acquired aplastic anemia and myelodysplastic syndrome: where next?
Haematologica. 2014 Apr;99(4):597-9. doi: 10.3324/haematol.2014.105569.
引用本文的文献
1
Modified Delphi panel consensus recommendations for management of severe aplastic anemia.
Blood Adv. 2024 Aug 13;8(15):3946-3960. doi: 10.1182/bloodadvances.2023011642.
2
Efficacy and safety of immunosuppressive therapy combined with eltrombopag for severe aplastic anemia: a systematic review and meta-analysis.
Syst Rev. 2024 Apr 4;13(1):101. doi: 10.1186/s13643-024-02515-2.
3
Progress in medical therapy in aplastic anemia: why it took so long?
Int J Hematol. 2024 Mar;119(3):248-254. doi: 10.1007/s12185-024-03713-3. Epub 2024 Feb 26.
4
Effect of Stanozolol combined with Cyclosporine A on aplastic anemia.
Am J Transl Res. 2023 Nov 15;15(11):6660-6666. eCollection 2023.
5
Levamisole Suppresses CD4 T-Cell Proliferation and Antigen-Presenting Cell Activation in Aplastic Anemia by Regulating the JAK/STAT and TLR Signaling Pathways.
Front Immunol. 2022 Jul 14;13:907808. doi: 10.3389/fimmu.2022.907808. eCollection 2022.
6
[Alternative donor HSCT for 109 children with acquired severe aplastic anemia: a single center retrospective analysis].
Zhonghua Xue Ye Xue Za Zhi. 2020 Feb 14;41(2):128-131. doi: 10.3760/cma.j.issn.0253-2727.2020.02.008.
7
Cord blood infusion-accelerated hematopoietic recovery after combined immunosuppressive therapy with fludarabine and rabbit ATG in severe aplastic anemia.
Int J Hematol. 2020 Mar;111(3):360-368. doi: 10.1007/s12185-019-02807-7. Epub 2020 Jan 3.
8
Activity of eltrombopag in severe aplastic anemia.
Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):450-456. doi: 10.1182/asheducation-2018.1.450.
9
Activity of eltrombopag in severe aplastic anemia.
Blood Adv. 2018 Nov 13;2(21):3054-3062. doi: 10.1182/bloodadvances.2018020248.
10
Clinical outcomes in adult patients with aplastic anemia: A single institution experience.
Am J Hematol. 2017 Dec;92(12):1295-1302. doi: 10.1002/ajh.24897. Epub 2017 Sep 25.
本文引用的文献
1
Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study.
Haematologica. 2009 Mar;94(3):348-54. doi: 10.3324/haematol.13829. Epub 2009 Jan 30.
2
TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements.
Blood. 2009 Jan 8;113(2):309-16. doi: 10.1182/blood-2008-07-166421. Epub 2008 Oct 17.
3
Cyclosporin A response and dependence in children with acquired aplastic anaemia: a multicentre retrospective study with long-term observation follow-up.
Br J Haematol. 2008 Jan;140(2):197-205. doi: 10.1111/j.1365-2141.2007.06903.x.
4
Granulocyte-stimulating factor and severe aplastic anemia: a survey by the European Group for Blood and Marrow Transplantation (EBMT).
Blood. 2007 Apr 1;109(7):2794-6. doi: 10.1182/blood-2006-07-034272.
5
Immunosuppressive therapy for acquired severe aplastic anemia (SAA): a prospective comparison of four different regimens.
Exp Hematol. 2006 Jul;34(7):826-31. doi: 10.1016/j.exphem.2006.03.017.
6
Current concepts in the pathophysiology and treatment of aplastic anemia.
Blood. 2006 Oct 15;108(8):2509-19. doi: 10.1182/blood-2006-03-010777. Epub 2006 Jun 15.
7
Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia.
Br J Haematol. 2006 Jun;133(6):622-7. doi: 10.1111/j.1365-2141.2006.06098.x.
8
Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil.
Br J Haematol. 2006 Jun;133(6):606-11. doi: 10.1111/j.1365-2141.2006.06085.x.
9
Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival.
Blood. 2005 Sep 15;106(6):2102-4. doi: 10.1182/blood-2005-03-0874. Epub 2005 Jun 2.
10
A third course of anti-thymocyte globulin in aplastic anaemia is only beneficial in previous responders.
Br J Haematol. 2005 Apr;129(1):110-7. doi: 10.1111/j.1365-2141.2005.05406.x.
Zotero 插件